Scott Mendel
Direktor/Vorstandsmitglied bei AKOYA BIOSCIENCES, INC.
Vermögen: 337 237 $ am 30.04.2024
Profil
Mr. Scott Mendel is an Independent Director at Akoya Biosciences, Inc. He is on the Board of Directors at Quantum-Si, Inc., Agendia, Inc., Akoya Biosciences, Inc. and Visby Medical, Inc. Mr. Mendel was previously employed as a President & Chief Executive Officer by GenMark Diagnostics, Inc., a Chief Financial Officer by Active Network LLC, and a CFO-Healthcare Information Technology Division by General Electric Co. He received his undergraduate degree from Indiana University and an MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
16.05.2024 | 141 843 ( 0,12% ) | 228 367 $ | 30.04.2024 | |
AKOYA BIOSCIENCES INC
0,06% | 31.03.2024 | 28 500 ( 0,06% ) | 108 870 $ | 30.04.2024 |
Aktive Positionen von Scott Mendel
Unternehmen | Position | Beginn |
---|---|---|
AKOYA BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 11.06.2021 |
QUANTUM-SI INCORPORATED | Direktor/Vorstandsmitglied | 15.05.2023 |
Visby Medical, Inc.
Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | Direktor/Vorstandsmitglied | 04.01.2022 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Direktor/Vorstandsmitglied | 06.01.2022 |
Ehemalige bekannte Positionen von Scott Mendel
Unternehmen | Position | Ende |
---|---|---|
ACTIVE NETWORK INC | Finanzdirektor/CFO | 01.12.2013 |
GE AEROSPACE | Corporate Officer/Principal | 01.03.2010 |
GENMARK DIAGNOSTICS, INC. | Vorstandsvorsitzender | - |
Ausbildung von Scott Mendel
Indiana University | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
GE AEROSPACE | Producer Manufacturing |
AKOYA BIOSCIENCES, INC. | Health Technology |
QUANTUM-SI INCORPORATED | Technology Services |
Private Unternehmen | 4 |
---|---|
Active Network LLC
Active Network LLC Packaged SoftwareTechnology Services Active Network LLC engages in cloud based activity and participant management solutions. It offers software solutions for race management, recreation management, outdoor management, camp management, church management, ski and attractions, sports management, school management, and swim management. The company was founded by Scott Galen Kyle, Mitchell F. Thrower, David Alberga, and Jim Woodman in 1999 and is headquartered in Dallas, TX. | Technology Services |
GenMark Diagnostics, Inc.
GenMark Diagnostics, Inc. Medical SpecialtiesHealth Technology GenMark Diagnostics, Inc. engages in the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary eSensor detection technology. Its solutions include ePlex System and XT-8 System. The company was founded by Jon Faiz Kayyem in 1993 and is headquartered in Carlsbad, CA. | Health Technology |
Visby Medical, Inc.
Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | Health Technology |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |